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Abstract
Colorectal and pancreatic cancers remain important contributors to cancer mortality burden and, therefore, new
therapeutic approaches are urgently needed. Rosemary (Rosmarinus officinalis L.) extracts and its components have been
reported as natural potent antiproliferative agents against cancer cells. However, to potentially apply rosemary as a
complementary approach for cancer therapy, additional information regarding the most effective composition, its
antitumor effect in vivo and its main molecular mediators is still needed. In this work, five carnosic acid-rich supercritical
rosemary extracts with different chemical compositions have been assayed for their antitumor activity both in vivo (in nude
mice) and in vitro against colon and pancreatic cancer cells. We found that the antitumor effect of carnosic acid together
with carnosol was higher than the sum of their effects separately, which supports the use of the rosemary extract as a
whole. In addition, gene and microRNA expression analyses have been performed to ascertain its antitumor mechanism,
revealing that up-regulation of the metabolic-related gene GCNT3 and down-regulation of its potential epigenetic
modulator miR-15b correlate with the antitumor effect of rosemary. Moreover, plasmatic miR-15b down-regulation was
detected after in vivo treatment with rosemary. Our results support the use of carnosic acid-rich rosemary extract as a
complementary approach in colon and pancreatic cancer and indicate that GCNT3 expression may be involved in its
antitumor mechanism and that miR-15b might be used as a non-invasive biomarker to monitor rosemary anticancer effect.
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Introduction
Colorectal cancer is the third most diagnosed cancer type in
males and the second in females worldwide, and its incidence is
increasing even in traditionally low-risk countries such as Spain
[1]. Moreover, mortality rates caused by colorectal cancer remain
high, being the fourth and third cause of cancer-related mortality
in males and females, respectively [1]. On the other hand,
pancreatic cancer affects 250 000 individuals worldwide annually
[2]. Although its incidence rates are not very high, it is one of the
most lethal tumors, representing the five and fourth cause of
cancer-related mortality in males and females, respectively, in
developed countries [1]. Therefore, new complementary thera-
peutic approaches, ideally cost-effective and non-toxic, are needed
to improve efficacy and quality of life of patients with these cancer
types.
Rosemary (Rosmarinus officinalis L.) and many of its components
were reported to possess chemopreventive properties in skin [3]
and breast [4] cancers in vivo, mostly by inhibiting 7,12-
dimethylbenz(a)anthracene (DMBA)-DNA adduct formation.
Moreover, they exert antioxidant activity both in vitro [5,6] and
in vivo [7], thus inhibiting genotoxicity, which is a significant
contributory cause of cancer, and protecting from carcinogens or
toxic agents. They also were reported to display antiproliferative
activity in vitro against breast [8–10], leukemia [8,9,11], hepatoma
[9,11–13], colon [11,14–16], lung [9], prostate [9], ovarian
[13,17], and urinary bladder [10] cancer cells. However, the
effect of rosemary on pancreatic carcinoma cells has not been
reported to date. Regarding the tumor progression in vivo, the
effect of rosemary extract in combination with an analogue of
1,25-dihydroxyvitamin D3 was assessed in a syngeneic mouse
leukemia tumor model, and showed a strong cooperative
antitumor effect [18].
Several rosemary components, such as carnosic acid [9,11],
carnosol [3,11,17], ursolic acid [3], as well as some of its essential
oil constituents [13], have been proposed to be responsible for the
anticancer effects of rosemary extracts. Although the concentra-
tion ratios of carnosol and carnosic acid were reported to influence
the antioxidant and antimicrobial activities [19], the possible
synergism of the rosemary components regarding the antitumor
activity of rosemary extracts has not been reported yet.
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Rosemary and its components were reported to modulate
several pathways, such as those related to antioxidant response
(e.g. glutathione metabolism [20] and Nfr2-dependent pathway
[21]), AMPK and PPAR pathways [22], as well as apoptosis-
related genes [17], but the molecular mechanism responsible for its
antitumor effects is not completely understood yet. In order to
properly apply rosemary as a nutritional supplement for cancer
therapy, additional information regarding the most effective
composition, its antitumor effect in vivo and its main molecular
mediators is still needed. In this sense, we have previously reported
the synergistic effect of the combination of supercritical fluid
rosemary extract and 5-fluorouracil, the most commonly used
drug in colon cancer therapy, through the modulation of TK1 and
TYMS, which are enzymes related to the mechanism of action of
this drug [16].
In this work, the antitumor activities of five carnosic-acid rich
supercritical rosemary extracts (RE’s) with different chemical
composition have been assayed in colon and pancreatic cancer
cells with the aim of determining the most potent RE and the
different sensitivity among the cell lines, as well as the contribution
of isolated components to the antitumor effect of the RE and the
possible cooperative effect of their combination. Moreover, the
effect of RE’s on tumor progression in vivo has been assessed in
colon cancer mouse xenografts. Furthermore, gene and miRNA
expression analysis were studied after RE treatment in order to
elucidate the molecular mechanism responsible for its antitumor
activity both in vitro and in vivo.
Materials and Methods
1. RE’s and isolated compounds
RE’s were obtained from Rosmarinus officinalis L. leaves as
previously described in Vicente et al., 2013 [23]. Briefly,
extractions were performed using a supercritical fluid pilot plant
(Thar Technology, Pittsburgh, PA, USA, model SF2000). The
temperature of the extraction cell and separators was maintained
at 40uC, and the CO2 flow rate was 60 g/min. An amount of
0.5 kg of dried and grinded rosemary leaves were employed in
each extraction assay. Different conditions (pressure, amount of
ethanol as co-solvent and extraction time) were applied in order to
obtain different RE’s with increasing concentration of bioactive
compounds (Table 1). Carnosic acid and carnosol were quantified
by HPLC analysis, and essential oil components were determined
by GC-MS analysis. The detailed methods for these determina-
tions were previously described by Vicente et al. [23]. Carnosic
acid ($97.0% w/w) was purchased from TCI Europe (Belgium),
and carnosol ($98% w/w) was acquired from Sigma-Aldrich.
2. Cell culture
Human colon (SW620 and DLD-1) cancer cells were obtained
from American Type Culture Collection (ATCC, Manassas, VA,
USA), and human pancreatic (MIA-PaCa-2 and PANC-1) cancer
cells were acquired from Sigma-Aldrich. SW620, MIA-PaCa-2
and PANC-1 cells were cultured in DMEM, while DLD-1 cells
were cultured in Roswell Park Memorial Institute (RPMI)-1640
medium. Both culture mediums were supplemented with 10%
fetal bovine serum (FBS), 2 mmol/L glutamine, and 1% of
antibiotic-antimycotic solution (containing 10 000 units/mL of
penicillin base, 10 000 mg/mL of streptomycin base, and 25
000 ng/mL of amphotericin B)(Gibco, Grand Island, NY, USA).
The cells were maintained under standard conditions of temper-
ature (37uC), humidity (95%), and carbon dioxide (5%).
3. Cell viability assay
Cell viability was determined by the 3-(4,5-dimethyl-thyazol-2-
yl)-2,5-diphenyl-tetrazolium (MTT) assay as previously described
[16]. Briefly, 20 000–30 000 cells were seeded in 24-well plates,
attached overnight, and treated with increasing concentrations of
RE’s. Following 48 h treatment, cells were incubated with MTT
solution during 3 hours, and absorbance of the MTT metabolic
product, which correlates with cell viability, was measured at
5601nm. At least three independent experiments were performed
in quadruplicate. IC50 values (concentrations that caused 50% of
cell viability inhibition) were calculated using a logistic regression.
4. Western blot analysis
Western blotting was performed to investigate the effect of RE’s
on the cleavage of PARP1 as previously described [16]. Briefly,
cell proteins were separated by sodium-dodecyl-sulfate-PAGE
electrophoresis, transferred to a nitrocellulose membrane and
blocked with 5% BSA in TTBS buffer. Primary antibodies anti-
PARP1 (BD Pharmingen) and anti-b-actin (Sigma-Aldrich) were
used at 1/125 and 1/2 000, respectively, and anti-mouse IgG
conjugated to horseradish peroxidase (GE Healthcare) was used at
1/40 000 as a secondary antibody to allow visualization by
chemiluminescence using the Amersham ECL Prime WB Detec-
tion Reagent (GE Healthcare, Little Chalfont, UK). Molecular
weights of protein bands were determined by the TotalLab
software (TotalLab, Newcastle, UK). b-actin determination was
used as an endogenous control of total protein quantity.
5. Tumorigenicity in nude mice
Female nude mice (Hsd:Athymic Nude-Foxn1nu) of 6 weeks of
age were purchased from Harlan Laboratories S.A. (Barcelona,
Spain) for tumorigenicity assays. Xenografts of human colon
cancer cells (SW620) were established by subcutaneously injecting
106 cells suspended in 0.2 mL of 1:1 mixture of DMEM and
matrigel (BD Biosciences), as previously described [24]. Mice were
then randomly divided into the groups (n = 8–10). RE was
administered to test groups in the drinking water (1 mg RE/
mL). The vehicle of the RE (absolute ethanol) was added to the
drinking water of control groups at the same proportion as in the
test groups (20 mL/mL). Tumor volume was measured twice a
week during approximately 5 weeks. The experiment was
approved by the Ethics Committee on Human and Animal
Experimentation of the Biomedical Research Institute (CSIC-
UAM, Madrid, Spain). Mice were kept in a pathogen-free housing
(laboratory accreditation number: ES280790000188) with water
and food ad libitum, 12-hour cycles of light/dark, and temperature
maintained at 2262uC in agreement with the Spanish institutional
guidelines for the care and use of laboratory animals (RD 53/
2013). In order to minimize animal suffering, behavior, mood and
weight of animals were controlled to detect possible signs of
toxicity, and a maximum tumor volume threshold of 1.2 cm3 was
established to indicate the end of the experiment. Then, the
animals were sacrificed with the use of CO2 (with gradual release
of gas) in agreement with the European Directive 2010/63/UE
and the Spanish guidelines (RD 53/2013). Afterwards, a sample of
blood was collected in Sarstedt Multivette 600 EDTA tubes
(Sarstedt), and centrifuged at 1500 g during 10 minutes for
extraction of plasma samples, which were maintained at 280uC.
6. Total RNA extraction
RNeasy kit or miRNeasy kit (Qiagen, Valencia, CA, USA) were
used according to the manufacturer’s protocol to obtain total RNA
or total RNA including miRNAs, respectively. The quantity and
miR-15b and GCNT3 in Rosemary Antitumor Effect
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purity of the obtained total RNA samples were determined by
UV-spectroscopy (NanoDrop 2000 Spectrophotometer, Thermo
Fisher Scientific, Waltham, MA, USA). For total RNA (including
miRNAs) extraction from mouse plasma samples, the protocol was
modified as follows: 500 mL of RWT buffer was used at first
washing, RPE buffer washing was performed three times, and
column containing the RNA was then centrifuged at 15 000 g
during 2 minutes and air-dried during 1 minute before RNA
elution.
7. Gene expression analysis
Microarray hybridization was commissioned from NIMgenetics
S.L. (Madrid, Spain). RNA quality control was performed in a
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA),
obtaining RNA integrity numbers (RIN) $8. Complementary
RNAs were prepared for hybridization in an Agilent G4112F
platform (Whole Human Genome Microarray 44k) using the One-
Color gene expression system (Agilent Technologies) according to
the manufacturer’s instructions. Microarray data were extracted
with Feature Extraction Software version 10.7 (Agilent Technol-
ogies), and expression data analysis was carried out with
Babelomics (http://babelomics.bioinfo.cipf.es) [25], using the
Agilent one-channel workflow. The background correction meth-
od selected was the one specific for Agilent arrays, and
normalization was performed by using the quantile normalization
method. Differential expression was assessed by using the LIMMA
method. Benjamini and Hochberg false discovery rate (FDR) was
applied for multiple test correction, and an adjusted p-value,0.05
was considered as statistically significant. An additional cutoff
threshold of 50% change in gene expression was used to define a
gene as being differentially regulated. Complete results of
microarray analysis can be found in Gene Expression Omnibus
(GEO) database (accession number: GSE56496).
Individual gene expression analysis was performed by quanti-
tative RT-PCR (qRT-PCR). To that end, 400 ng RNA was
reverse-transcribed to cDNA using the High Capacity RNA-to-
cDNA Master Mix system (Applied Biosystems, Carlsba, CA,
USA), as directed by the manufacturer. For gene expression
analysis of GCNT3, we used the specific Taqman gene expression
assay Hs01921181_s1 (Applied Biosystems). qRT-PCR was
performed in the 7900HT Real-Time PCR System (Applied
Biosystems), according to the manufacturer’s protocol. 18S
expression in each sample was used as endogenous control
(specific assay Hs99999901_s1, Applied Biosystems). qRT-PCR
data extraction was performed using the RQ Manager software
(Applied Biosystems), and the 22DDCt method was used to
calculate the relative expression of each gene (RQ = 22DDCt) as
previously described [26].
8. miRNA expression analysis
The screening of the modulation of 754 different miRNAs by
RE was carried out by using the TaqMan Array Human
MicroRNA A+B Cards Set v3.0 (Applied Biosystems). To that
end, miRNA reverse transcription was performed with the
TaqMan miRNA Reverse Transcription kit and the Megaplex
Primer Pools, Human Pools set v3.0. Afterwards, qRT-PCR was
performed with the cards set and the TaqMan Universal PCR
Master Mix No AmpErase UNG (Applied Biosystems) in the
7900HT Real-Time PCR System (Applied Biosystems), as
directed by the manufacturer, and analyzed by the 22DDCt
method [26]. In order to determine the miRNAs that target
GCNT3 gene according to in silico analysis, we checked four
different databases (miRanda, TargetScan, Diana-microT, and
PITA) and mirSVR score values from http://www.microrna.org/
microrna/getDownloads.do.
To determine the expression of individual miRNAs, the specific
TaqMan miRNA assay (ref. 000390 for miR-15b, and ref. 002182
for miR-939) was used according to the manufacturer’s protocol.
Retrotranscription of each miRNA was performed with TaqMan
miRNA Reverse Transcription Kit (Applied Biosystems) and the
specific primers and TaqMan Universal PCR Master Mix II no
UNG was used for the qRT-PCR, which was performed in the
7900HT Real-Time PCR System (Applied Biosystems).
9. Statistical analysis
Data are presented as mean6 SEM. Comparisons between two
groups were analyzed by Student’s t test or the non-parametric
alternative Mann-Whitney U test according to normality of data
distribution. The statistically significant differences among several
groups were determined by one-way ANOVA with Bonferroni’s
post hoc test. The statistical test used in each experiment is indicated
in the corresponding figure legend. Tumor volume comparisons
between control and treated groups were analyzed using repeated
measures ANOVA and Bonferroni’s test. Statistically significant
values are indicated by asterisks as follows: *p#0.05; **p#0.01;
Table 1. Extraction conditions and chemical composition of supercritical fluid rosemary extracts (RE’s).
Rosemary
extract Extraction and fractionation conditions
Carnosic acid
(% w/w)
Carnosol
(% w/w)
Main volatil
compoundsa (% w/w)
RE-1 P = 300 bar, t = 360 min 10.89 1.05 12.79
RE-2 P = 300 bar. First step: fractionationb during t = 60 min. Second step:
t = 300 min without fractionation. Sample from separator 1.
16.90 1.90 13.59
RE-3 P = 150 bar, C = 10%(w/w), t = 180 min. 18.33 1.95 4.69
RE-4 P = 150 bar, C = 5%(w/w), t = 180 min. 25.66 3.81 10.42
RE-5 First step: P = 300 bar, t = 360 min. Second step: P = 150 bar, C = 10%(w/w),
t = 180 min. Sample from second step.
30.69 2.58 2.04
aBorneol, bornyl acetate, camphor, 1,8-cineol and verbenone.
bFractionation of the extracted material was performed by setting pressure of the first separator (S1) to 100 bar, while the second separator (S2) was maintained at the
recirculation system pressure (50 bar).
P: extraction pressure, C: ethanol used as cosolvent (% w/w), t: extraction time.
doi:10.1371/journal.pone.0098556.t001
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***p#0.001. IBM SPSS Statistics version 20 (SPSS Inc., Chicago,
IL) was used for statistical analysis.
Results
1. RE’s obtained by supercritical fluid technology
Rosmarinus officinalis L. leaves were used as starting material for
supercritical fluid extraction by applying different conditions of
pressure, percentage of ethanol as co-solvent, and extraction time
(Table 1). Five RE’s with different composition and antioxidant
activity were obtained, and used to examine their antitumor
activities.
2. Differential cell viability inhibitory activity of
supercritical RE’s on colon and pancreatic cancer cells
The effect of the five different RE’s obtained by supercritical
fluid technology on cell viability of colon (SW620 and DLD-1) and
pancreatic (PANC-1 and MIA-PaCa-2) cancer cells was assessed
by the MTT assay. The IC50 values of each RE in the different
cell types were calculated in order to compare the potency of the
RE’s in each cell line, and the sensitivity of the cell lines to each
RE. The results indicated that PANC-1 (pancreatic cancer) is the
most resistant cancer cell line to the effect of the RE’s, followed by
MIA-PaCa-2 (pancreatic cancer), and colon cancer SW620 and
DLD-1 cell lines, which are the most sensitive. Therefore, RE’s
Figure 1. Viability inhibition and death induction of colon and pancreatic cancer cells by five different RE’s. Colon (SW620 and DLD-1)
and pancreatic (MIA-PaCa-2 and PANC-1) cancer cells were treated with increasing concentrations of five different RE’s during 48 h and cell viability
was determined by MTT assay. (A) Bars represent the IC50 values (50% cell viability inhibition) of the five different RE’s in each cancer cell line. (B-C)
IC50s of the five RE’s in the four cancer cell lines plotted against the carnosic acid (B) or carnosol (C) content of the RE’s. IC50 values are expressed as
the mean 6 SEM of at least three independent experiments, each performed in quadruplicate. (D-E) PARP1 cleavage induced by different RE’s in
colon and pancreatic cancer cells after 48 h treatment. (D) Colon cancer cells (DLD-1) were treated with 70 mg/mL of five different RE’s (RE-1 to RE-5)
or vehicle (Cntrl). (E) Two colon (DLD-1 and SW620) and two pancreatic (MIA-PaCa-2 and PANC-1) cancer cell lines were treated with 110 mg/mL of
RE-3, 90 mg/mL of RE-4 or vehicle (Cntrl). Western blot figures show representative results of three independent experiments. DLD: DLD-1, M: marker
of molecular weight, MIA: MIA-PaCa-2, P: PANC-1, RE: supercritical rosemary extract, SW: SW620.
doi:10.1371/journal.pone.0098556.g001
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appear to be more effective in inhibiting cell viability of colon
cancer cells in comparison to pancreatic cancer cells.
Regarding the different RE’s, RE-1 is the less potent, while RE-
4 and RE-5 are the most potent inhibitors of colon and pancreatic
cancer cell viability (Figure 1A). RE-2 and RE-3 show similar
effects, which are intermediate between that of RE-1 and RE’s 4
and 5. Although RE-5 possesses a higher content in carnosic acid
than RE-4, its effect on cell viability is similar or even lower than
that of RE-4. This difference might be attributed to the higher
content of carnosol and/or essential oil of RE-4 in comparison
with RE-5. Interestingly, while RE-4 activity in colon cancer cells
is similar to that of RE-5, pancreatic cancer cells appear to be
more sensitive to RE-4 than to RE-5. This could be explained by a
different sensitivity of pancreatic cancer cells to carnosol and/or
essential oil in comparison to colon cancer cells since the ratios
carnosol:carnosic acid and essential oil:carnosic acid are higher in
RE-4 than in RE-5 (see Table 1). Moreover, a synergistic effect of
the combination of carnosic acid and carnosol or volatile
compounds might explain the differential effect of these two
RE’s. The potency of the RE’s (IC50) was plotted against carnosic
acid or carnosol content (both previously reported to be
responsible for the antitumor activities of rosemary) in order to
observe the correlations between these characteristics and the
effect of the RE’s on cell viability. The plot against carnosic acid
(Figure 1B) shows a correlation between this compound and cell
viability inhibition until RE-4 (25.66% w/w carnosic acid), but
RE-5, with a higher carnosic acid content (30.69% w/w), shows a
similar effect on colon cancer cells and even a lower effect on
Figure 2. Inhibition of cancer cell viability by different RE’s in comparison with their major active components. Cell viability inhibition
of cancer cells by different RE’s and their equivalent concentrations of carnosic acid alone, carnosol alone, or both compounds in combination. SW620
colon and PANC-1 pancreatic cancer cells were treated with increasing concentrations of RE-2, RE-4 and RE-5, and the same concentrations of
carnosic acid, carnosol, and the combination of both present in the RE’s at each assayed condition. Extract ID and tumor cell line used in the assay are
indicated in each graph. Results are shown as the mean 6 SEM of three independent experiments, each performed in quadruplicate. Asterisks
indicate statistically significant differences of carnosic acid or extract in comparison with the combination of carnosic acid and carnosol (U de Mann-
Whitney; *p#0.05; **p#0.01). RE: supercritical rosemary extract.
doi:10.1371/journal.pone.0098556.g002
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pancreatic cancer cells in comparison with RE-4. On the contrary,
the plot against carnosol content (Figure 1C) shows a good
correlation in pancreatic cancer cells, while the effects of RE’s 4
and 5, although the former contains approximately 50% more
carnosol than the latter, is very similar in colon cancer cells.
Therefore, despite both carnosol and carnosic acid show a
relatively good correlation with the cell viability inhibitory effect
of the RE’s, none of these compounds on its own completely
explain their different antitumor potency.
3. Differential induction of apoptosis by five different RE’s
in colon and pancreatic cancer cells
In order to compare the induction of cell death on colon and
pancreatic tumor cells by the different RE’s we analyzed PARP1
cleavage by western blot. On the one hand, the same cell line
(DLD-1) was treated with the different RE’s at the same
concentration, in order to assess their different potency in inducing
tumor cell death. Figure 1D indicates that the five RE’s are able to
induce tumor cell death at 70 mg/mL, although RE-1 is the less
active and RE’s 4 and 5 are the most active extracts in relation to
this effect. This result is also consistent with the results obtained in
cell viability experiments, confirming the lowest activity of RE-1
and the highest activity of RE-4 and RE-5 in both inhibiting cell
viability and inducing death of cancer cells.
On the other hand, colon (DLD-1 and SW620) and pancreatic
(PANC-1 and MIA-PaCa-2) cancer cells were treated with the
same concentration of RE-3 or RE-4 to determine the sensitivity
of the different cell lines to the RE’s. As it can be observed in
Figure 1E, colon cancer DLD-1 cell line is the most sensitive while
pancreatic cancer PANC-1 cell line is the less sensitive to the cell
death induction by both RE’s. This is consistent with the results
previously obtained in cell viability, and confirms the different
sensitivity of the colon and pancreatic cancer cell lines to the
antitumor effects of the RE’s.
4. Carnosic acid antitumor effect on colon and pancreatic
cancer cells is significantly enhanced by minimal
concentrations of carnosol
With the aim of determining which is the contribution of the
content of carnosic acid and carnosol to the antitumor activity of
the RE’s, and thus explain the different activities of the five RE’s,
we assayed the effect on cell viability of the different RE’s in
comparison with the effect of the same concentrations of carnosic
acid and carnosol present in the RE, both separately and in
combination, in colon (SW620) and pancreatic (PANC-1) cancer
cells (Figure 2). We observed that the concentrations of carnosic
acid found in RE’s inhibited tumor cell viability in a dose-
dependent manner, while carnosol at those concentrations did not
show any effect on cell viability. Surprisingly, carnosol at these
inactive concentrations significantly potentiated the activity of
carnosic acid. Therefore, the combination of carnosic acid and
carnosol found in the three RE’s is more effective than the carnosic
acid alone, even though the low concentration of carnosol present
in the RE is ineffective on its own. However, the effect of the RE is
significantly higher than the combination of the equivalent
concentrations of carnosol and carnosic acid, indicating that
additional components of the RE’s (e.g. volatile oil compounds)
contribute to their inhibitory effect on tumor cell viability.
5. Oral intake of RE’s inhibits tumor growth of colon
cancer xenografts in nude mice
In order to assay the effect of the RE’s on tumor progression in
vivo we administered RE-3, RE-4 or RE-5 in the drinking water to
nude mice bearing human colon cancer xenografts. The results
indicated that the three different RE’s assayed possess the ability to
significantly inhibit tumor volume in vivo (Figure 3). Since the
tumor cells were already present in the organism when the
treatment with RE started, these results suggest that RE’s might
not only act as a putative chemopreventive agent as previous
works indicate, but also as an effective agent in blocking tumor
development and progression. We did not detect any significant
change in the behavior, mood and weight of the animals along the
duration of the experiment, indicating the lack of toxicity of the
RE’s under these conditions of administration. Although the
volume inhibition at the end of the experiment caused by the
different RE’s was very similar (27.2%, 26.4% and 24.4% by RE-
3, RE-4 and RE-5, respectively), the effect appeared later in RE-3
in comparison with RE-4 and RE-5, which is consistent with the
lower activity of RE-3 observed in vitro in comparison with RE-4
and RE-5.
Figure 3. Antitumorigenic activity of different RE’s in human
colon cancer xenografts. RE (test groups) or vehicle (control groups)
was administered to nude mice bearing SW620 colon cancer xenografts
in the drinking water (1 mg RE and 20 mL ethanol as vehicle per mL of
drinking water). Three RE’s with different composition (RE-3, RE-4 and
RE-5, indicated in each graph) were assayed. Tumor volumes were
monitored twice a week during 32–35 days. Results are shown as mean
6 SEM (n = 16–20) and repeated measures ANOVA with Bonferroni’s
test was used to determine the statistically significant differences
between treated and control groups (*p#0.05; **p#0.01; ***p#0.001).
RE: supercritical rosemary extract.
doi:10.1371/journal.pone.0098556.g003
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Figure 4. Modulation of gene and miRNA expression by RE. (A) Venn diagram representing overlap of the genes significantly modulated (p,
0.05 and fold change (FC) .650%) by RE-2 at 30, 60 and 100 mg/mL after 48 h treatment in SW620 cells according to microarray data. (B) Up-
regulation of GCNT3 gene expression in SW620 colon cancer cells by five RE’s with different composition (RE-1, RE-2, RE-3, RE-4 and RE-5) at the same
concentration (90 mg/mL) during 48 h. Bars represent the mean 6 SEM of two independent experiments, each performed with biological triplicates
and technical duplicates. ANOVA with Bonferroni’s post hoc test was applied to test statistically significant differences among RE’s. (C) Up-regulation
of GCNT3 gene expression in SW620 colon cancer cells by 48 h treatment with RE-4 at 60 mg/mL and carnosic acid, carnosol, and the combination of
both compounds at the concentrations present in this RE. Bars represent the mean 6 SEM of two independent experiments, each performed with
biological triplicates and technical duplicates. Student’s t test was applied to determine the statistically significant differences between treated and
control cells. (D) Down-regulation of miR-15b gene expression in SW620 colon cancer cells by 48 h treatment with RE-4 at 60 mg/mL and carnosic
acid, carnosol, and the combination of both compounds at the concentrations present in this RE. Student’s t test was used to test statistically
significant differences between treated and control cells. (E) Modulation of miR-15b and miR-939 (as a negative control) in plasma of colon cancer
xenograft nude mice after orally intake of RE-5 (1 mg/mL in drinking water), in comparison with the control group of mice. Bars represent mean 6
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6. Antitumor effect of RE’s correlates with up-regulation
of glycosyltransferase GCNT3 gene expression
In order to gain an insight into the antitumor mechanism of
action of RE’s, microarray analysis was performed. To that end,
RNA was extracted from SW620 cells treated with increasing
concentrations of RE-2. The numbers of genes whose expression
was significantly altered in comparison with the control (p,0.05
and 650% expression change) are shown in Figure 4A, and genes
modulated at the three concentrations assayed are presented in
Table 2. On the basis of its dose-dependent induction and its
reported activity as tumor suppressor [27], GCNT3 was selected
as one of the genes potentially involved in the antitumor
mechanism of action of RE. On the other hand, the analysis of
the expression of miRNAs targeting GCNT3 showed that miR-15
family is significantly down-regulated by RE-2 (Table 3). More-
over, GCNT3 expression was analyzed in colon cancer cells
treated with the five different RE’s at the same concentration
(90 mg/mL). The results indicate that over-expression levels of
GCNT3 increases from RE-1 to RE-5 (Figure 4B), thus correlating
with the potency of these RE’s to inhibit cell viability and induce
cell death of colon cancer cells. As it can be observed, carnosic
acid is the main responsible for the induction of GCNT3
expression (Figure 4C) and miR-15b down-regulation (Figure 4D)
by RE, while carnosol did not show a significant effect in the
modulation of either GCNT3 or miR-15b at the concentrations
found in the RE.
7. Non-invasive monitoring of RE antitumor effect by
determining circulating miR-15b
Analysis of circulating miRNAs in plasma of mice with colon
cancer xenografts after orally intake of RE-5 (1 mg/mL in
drinking water) revealed that miR-15b is significantly down-
regulated by rosemary in comparison with the control group of
mice (Figure 4E), in agreement with the results observed in vitro.
The specificity of the down-regulation of miR-15b in mouse
plasma was assessed by the parallel analysis of miR-939
expression, which was used as a negative control. This result
suggests that circulating miR-15b levels, which analysis requires
minimal invasive methods, might be used to monitor the
antitumor effect of RE in vivo.
Discussion
Scientific literature reflects antitumor effects of several rosemary
extracts mainly on skin [3], breast [4], colon [16] and leukemia
[18], among other cancer types. Moreover, some rosemary
components such as carnosic acid and carnosol have been
reported to provide the antioxidant [19] and anticancer [11]
effects to rosemary extracts. However, the possible synergistic
effect of the combination of rosemary components has not been
addressed yet. In this work, we assayed the antitumor effect of
several supercritical RE’s with different composition on colon and
pancreatic cancer cells, in terms of cell viability and cell death. To
our knowledge, neither RE’s nor their main components have
been assayed to determine their antitumor activities in pancreatic
carcinoma to date. The results on cell viability show that the
sensitivity of tumor cells to the different RE’s is (from less sensitive
to more sensitive): PANC-1 (pancreas), MIA-PaCa-2 (pancreas),
SW620 (colon) and DLD-1 (colon). The results on apoptosis
induction also suggest that colon cancer cells might be more
sensitive than pancreatic cancer cells to the antitumor effects of the
extracts. Thus, the different potency of the RE’s previously
observed in cell viability by MTT assay correlates with their
potency in inducing cell death assessed by western blot analysis of
PARP1 cleavage. Future work is needed in order to find the
cellular or molecular characteristics that make PANC-1 cells
especially resistant to the antitumor effects of rosemary extracts.
Several advantages warrant the use of rosemary extracts, and
specifically supercritical extracts, instead of their isolated compo-
nents in cancer treatment. On the one hand, the obtaining of
rosemary extracts is much less expensive than the isolation of its
compounds. Moreover, supercritical rosemary extracts do not
contain chemical residues, which would entail harmful effects.
Indeed, supercritical fluid rosemary extract has been recognized as
a healthy component by the European Food Safety Authority
SEM (n = 8). Student’s t test was used to assess statistically significant differences between treated and control groups. * p#0.05, ** p#0.01, *** p#
0.001. RE: supercritical rosemary extract, Cc+Cl: Carnosic acid and carnosol.
doi:10.1371/journal.pone.0098556.g004
Table 2. Modulation of gene and miRNA expression by RE-2 in colon cancer cells.
30 mg/mL 60 mg/mL 100 mg/mL
HGNC.Symbol p value FCa p value FCa p value FCa
FUT3 0.00807 1.59 0.00172 1.59 0.00009 2.03
PLCB2 0.02310 2.16 0.01838 1.86 0.00092 2.56
CLIP4 0.00102 1.98 0.00008 2.17 0.00002 2.25
GCNT3 0.00654 1.54 0.00009 2.38 0.00002 2.49
CBR3 0.03568 1.61 0.00056 2.50 0.00008 2.88
AKR1B10 0.00045 2.27 0.00003 2.68 0.00001 2.46
BEST1 0.04765 2.05 0.00191 2.97 0.00175 2.58
CSTA 0.00455 2.49 0.00020 3.40 0.00006 3.32
DEFB103B 0.02419 2.07 0.00014 4.78 0.00003 5.18
Microarray data of significantly modulated genes in SW620 colon cancer cells after treatment during 48 h with three different concentrations (30, 60 and 100 mg/mL) of
RE-2.
aFC: Fold change.
doi:10.1371/journal.pone.0098556.t002
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(EFSA), and is currently used as an antioxidant food additive [28].
On the other hand, as we have demonstrated in this work the
combination of carnosol and carnosic acid exerts a higher effect
than the sum of their effects separately. Jordan et al. recently
reported the relationship between the carnosic acid and carnosol
content of RE’s with their antimicrobial and antioxidant activities
[19]. They found that the two diterpenes equally affected to the
antioxidant activity, whereas antimicrobial effect was higher when
the carnosol:carnosic acid ratio increased. Future studies are
warranted in order to determine the specific carnosol:carnosic acid
ratio needed to achieve the highest antitumor effect. Moreover,
additional rosemary components (e.g. volatile compounds) further
increase the antiproliferative effect of RE, thus contributing to the
higher antitumor activity of the extract in comparison to the effect
of the combination of its main components (carnosic acid and
carnosol).
In order to test the efficacy of RE in vivo, several RE’s were
orally administered to mouse colon cancer xenografts. Previous
animal studies found in the literature showed the preventive effect
or rosemary extract in vivo in several tumor types. In our
experiment, since the tumor cells are already in the organism at
the time of treatment, we demonstrate the inhibitory effect of
rosemary extract on tumor progression in vivo. The activities of the
three RE’s assayed (RE-3, RE-4 and RE-5) resulted very similar at
the end of the experiment despite cell viability in vitro experiments
showed the lesser efficacy of RE-3. However, the effect of RE-3
began later than those of RE-4 and RE-5. One explanation could
be the saturation of the absorption mechanisms of rosemary active
components in the bowel, but more experiments are needed to
address this issue.
Rosemary and their components were reported to modulate
glutathione metabolism [20], Nfr2-dependent pathway [21],
AMPK and PPAR pathways [22], among others, as well as
apoptosis-related genes [17]. However, the antitumor mechanism
of action is not completely understood. In this study, we observed
the up-regulation of GCNT3 by RE, and the correlation of this
up-regulation with its antitumor efficacy. The rosemary compo-
nent responsible for this modulation is carnosic acid. Since
GCNT3 has been previously reported to possess tumor suppressor
activities in colon cancer [27], it is up-regulated by several
chemotherapeutic drugs and its overexpression correlates with a
better outcome of colon cancer patients (Gonza´lez-Vallinas M et
al., submitted for publication) we propose that GCNT3 may be a
key molecule in the antitumor action of rosemary.
The finding that miR-15b, which was reported to target
GCNT3 by in silico analysis, correlated with the antitumor effect of
rosemary and can be found in mouse plasma, provides a potential
suitable biomarker to monitor the in vivo response to RE. In
addition, miR-15b has been recently proposed as potential
biomarker for colorectal cancer since it has been found up-
regulated in colorectal cancer patients, which suggests a relevant
role of this miRNA in the progression of the disease [29]. The
determination of the circulating miRNAs is a non-invasive and
relatively accessible method which could be useful in order to
discriminate the responder and non-responder individuals during
the treatment. Future work should be directed both to analyze the
functional role of these molecules in the action of this agent, and to
investigate their clinical value as potential molecular biomarkers.
Conclusions
In summary, our results indicate that RE exerts antitumor
activity on both colon and pancreatic cancers, probably through
the up-regulation of GCNT3 and the down-regulation of miR-
15b, and constitutes a promising therapeutic tool in the treatment
of patients suffering from these diseases. Moreover, down-
regulation of plasmatic miR-15b levels is proposed as a potential
non-invasive biomarker to monitor the anticancer effect produced
by RE.
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